MARKET

CPHRF

CPHRF

Cipher Phrmctcls
OTCQX
7.79
-0.17
-2.14%
Opening 12:02 03/17 EDT
OPEN
7.82
PREV CLOSE
7.96
HIGH
7.82
LOW
7.79
VOLUME
1.61K
TURNOVER
12.60K
52 WEEK HIGH
14.44
52 WEEK LOW
4.970
MARKET CAP
186.87M
P/E (TTM)
12.36
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at CPHRF last week (0310-0314)?
Weekly Report · 7h ago
Bearish Sentiment Across The Cannabis Space - Check Full Movers For March 13, 2025
Benzinga · 3d ago
Bullish Sentiment Across The Cannabis Space - Check Full Movers For March 11, 2025
Benzinga · 5d ago
Cannabis Stock Movers For March 10, 2025
Benzinga · 6d ago
Weekly Report: what happened at CPHRF last week (0303-0307)?
Weekly Report · 03/10 10:37
Watching Cannabis Stocks; Marijuana Moment Reports 'Trump White House Invites Proposal On Federal Marijuana Legalization, Activist Says'
Benzinga · 03/05 17:38
Weekly Report: what happened at CPHRF last week (0224-0228)?
Weekly Report · 03/03 10:36
Weekly Report: what happened at CPHRF last week (0217-0221)?
Weekly Report · 02/24 10:36
More
About CPHRF
Cipher Pharmaceuticals Inc. is a specialty pharmaceutical company with a diversified portfolio of commercial and early to late-stage products, mainly in dermatology. The Company acquires products that fulfill unmet medical needs, manages the required clinical development and regulatory approval process, and markets those products in Canada, the United States, and South America. Its dermatology products include Actikerall, Epuris, and Vaniqa. Its hospital acute care products include Aggrastat and Brinavess. Its out-licensed products include Absorica, ConZip and Lipofen. Durela is its specialty medicine. Its product pipeline includes MOB-015, CF-101, and DTR-001. It delivers novel products to healthcare professionals and patients in Canada in a range of therapeutic areas, including dermatology, women’s health, urology and others. It also has the Natroba operations and global product rights to Natroba and its authorized generic Spinosad, a topical treatment for both head lice and scabies.

Webull offers Cipher Pharmaceuticals Inc stock information, including OTCQX: CPHRF real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, CPHRF stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading CPHRF stock methods without spending real money on the virtual paper trading platform.